Glycemic memory associated epigenetic changes

Biochemical Pharmacology

Volumn 80, Issue 12, 2010, Pages 1853-1859

  Siebel, Andrew L ^a   Fernandez, Ana Z ^a,b   El Osta, Assam ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Venezuelan Institute for Scientific Research (IVIC)   (Venezuela)

Author keywords

Diabetes; Diabetic complications; Epigenetics; Histone modifications; Hyperglycemic memory

Indexed keywords

GLUCOSE; HISTONE; I KAPPA B; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPTOTAGMIN I;

DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIUM CELL; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENERGY METABOLISM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HUMANS; HYPERGLYCEMIA; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 78049444370     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.06.005     Document Type: Review

References (81)

1. Cooper M.E., Johnston C.I. Optimizing treatment of hypertension in patients with diabetes. J Am Med Assoc 2000, 283:3177-3179.
2. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001, 161:1717-1723.
3. Fox C.S., Coady S., Sorlie P.D., Levy D., Meigs J.B., D'Agostino R.B., et al. Trends in cardiovascular complications of diabetes. J Am Med Assoc 2004, 292:2495-2499.
4. Qiao Q., Pyorala K., Pyorala M., Nissinen A., Lindstrom J., Tilvis R., et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002, 23:1267-1275.
5. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353:2643-2653.
6. Chalmers J., Cooper M.E. UKPDS and the legacy effect. N Engl J Med 2008, 359:1618-1620.
7. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572.
8. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
9. Nathan D.M. Some answers, more controversy, from UKPDS United Kingdom Prospective Diabetes Study. Lancet 1998, 352:832-833.
10. Holman R.R., Paul S.K., Bethel M.A., Neil H.A., Matthews D.R. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008, 359:1565-1576.
11. Engerman R.L., Kern T.S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987, 36:808-812.
12. Roy S., Sala R., Cagliero E., Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990, 87:404-408.
13. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008, 205:2409-2417.
14. Brasacchio D., Okabe J., Tikellis C., Balcerczyk A., George P., Baker E.K., et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009, 58:1229-1236.
15. Gerstein H.C., Riddle M.C., Kendall D.M., Cohen R.M., Goland R., Feinglos M.N., et al. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007, 99:34i-43i.
16. Bird A. Perceptions of epigenetics. Nature 2007, 447:396-398.
17. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
18. Ozanne S.E., Constancia M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007, 3:539-546.
19. Talbert P.B., Henikoff S. Spreading of silent chromatin: inaction at a distance. Nat Rev Genet 2006, 7:793-803.
20. Jaenisch R., Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008, 132:567-582.
21. Matouk C.C., Marsden P.A. Epigenetic regulation of vascular endothelial gene expression. Circ Res 2008, 102:873-887.
22. Inui M., Martello G., Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010, 11:252-263.
23. Klug A., Rhodes D., Smith J., Finch J.T., Thomas J.O. A low resolution structure for the histone core of the nucleosome. Nature 1980, 287:509-516.
24. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389:251-260.
25. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
26. Li B., Carey M., Workman J.L. The role of chromatin during transcription. Cell 2007, 128:707-719.
27. Mack C.P. An epigenetic clue to diabetic vascular disease. Circ Res 2008, 103:568-570.
28. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
29. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
30. Huang J., Fan T., Yan Q., Zhu H., Fox S., Issaq H.J., et al. Lsh, an epigenetic guardian of repetitive elements. Nucleic Acids Res 2004, 32:5019-5028.
31. Shogren-Knaak M., Ishii H., Sun J.M., Pazin M.J., Davie J.R., Peterson C.L., et al. H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006, 311:844-847.
32. Ruthenburg A.J., Li H., Patel D.J., Allis C.D. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 2007, 8:983-994.
33. Koch C.M., Andrews R.M., Flicek P., Dillon S.C., Karaoz U., Clelland G.K., et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 2007, 17:691-707.
34. Tateishi K., Okada Y., Kallin E.M., Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 2009, 458:757-761.
35. Milagro F.I., Campion J., Garcia-Diaz D.F., Goyenechea E., Paternain L., Martinez J.A. High fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J Physiol Biochem 2009, 65:1-9.
36. Khan I.Y., Dekou V., Douglas G., Jensen R., Hanson M.A., Poston L., et al. A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regul Integr Comp Physiol 2005, 288:R127-R133.
37. Armitage J.A., Pearce A.D., Sinclair A.J., Vingrys A.J., Weisinger R.S., Weisinger H.S. Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency. Lipids 2003, 38:459-464.
38. Taylor P.D., McConnell J., Khan I.Y., Holemans K., Lawrence K.M., Asare-Anane H., et al. Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy. Am J Physiol Regul Integr Comp Physiol 2005, 288:R134-R139.
39. Schwer B., Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab 2008, 7:104-112.
40. Morgan H.D., Sutherland H.G., Martin D.I., Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 1999, 23:314-318.
41. Duhl D.M., Vrieling H., Miller K.A., Wolff G.L., Barsh G.S. Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994, 8:59-65.
42. Wolff G.L., Kodell R.L., Moore S.R., Cooney C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998, 12:949-957.
43. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8:253-262.
44. Cropley J.E., Suter C.M., Beckman K.B., Martin D.I. Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc Natl Acad Sci USA 2006, 103:17308-17312.
45. Miao F., Gonzalo I.G., Lanting L., Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004, 279:18091-18097.
46. Shanmugam N., Reddy M.A., Guha M., Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003, 52:1256-1264.
47. Hofmann M.A., Schiekofer S., Kanitz M., Klevesath M.S., Joswig M., Lee V., et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 1998, 21:1310-1316.
48. Xue J.H., Yuan Z., Wu Y., Liu Y., Zhao Y., Zhang W.P., et al. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res 2010, 86:141-150.
49. Li Y., Reddy M.A., Miao F., Shanmugam N., Yee J.K., Hawkins D., et al. Role of the histone H3 lysine 4 methyltransferase SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes Relevance to diabetes and inflammation. J Biol Chem 2008, 283:26771-26781.
50. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
51. Libby P., Plutzky J. Diabetic macrovascular disease: the glucose paradox?. Circulation 2002, 106:2760-2763.
52. Dragomir E., Simionescu M. Monocyte chemoattractant protein-1-a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem 2006, 112:239-244.
53. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
54. Dillon S.C., Zhang X., Trievel R.C., Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 2005, 6:227.
55. Martin C., Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005, 6:838-849.
56. Bannister A.J., Kouzarides T. Reversing histone methylation. Nature 2005, 436:1103-1106.
57. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
58. Shi Y., Whetstine J.R. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007, 25:1-14.
59. Deering T.G., Ogihara T., Trace A.P., Maier B., Mirmira R.G. Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 2009, 58:185-193.
60. Reddy M.A., Villeneuve L.M., Wang M., Lanting L., Natarajan R. Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res 2008, 103:615-623.
61. Villeneuve L.M., Reddy M.A., Lanting L.L., Wang M., Meng L., Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA 2008, 105:9047-9052.
62. Bieliauskas A.V., Pflum M.K. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev 2008, 37:1402-1413.
63. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009, 49:243-263.
64. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009, 10:32-42.
65. Granger A., Abdullah I., Huebner F., Stout A., Wang T., Huebner T., et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 2008, 22:3549-3560.
66. Jenuwein T. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol 2001, 11:266-273.
67. Czvitkovich S., Sauer S., Peters A.H., Deiner E., Wolf A., Laible G., et al. Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice. Mech Dev 2001, 107:141-153.
68. Fuks F., Hurd P.J., Deplus R., Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 2003, 31:2305-2312.
69. Peters A.H., O'Carroll D., Scherthan H., Mechtler K., Sauer S., Schofer C., et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107:323-337.
70. Chen Y., Yang Y., Wang F., Wan K., Yamane K., Zhang Y., et al. Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc Natl Acad Sci USA 2006, 103:13956-13961.
71. Huang J., Sengupta R., Espejo A.B., Lee M.G., Dorsey J.A., Richter M., et al. p53 is regulated by the lysine demethylase LSD1. Nature 2007, 449:105-108.
72. Opel M., Lando D., Bonilla C., Trewick S.C., Boukaba A., Walfridsson J., et al. Genome-wide studies of histone demethylation catalysed by the fission yeast homologues of mammalian LSD1. PLoS One 2007, 2:e386.
73. Yamane K., Toumazou C., Tsukada Y., Erdjument-Bromage H., Tempst P., Wong J., et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006, 125:483-495.
74. Klose R.J., Kallin E.M., Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 2006, 7:715-727.
75. Klose R.J., Yamane K., Bae Y., Zhang D., Erdjument-Bromage H., Tempst P., et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 2006, 442:312-316.
76. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000, 64:435-459.
77. Stimson L., Rowlands M.G., Newbatt Y.M., Smith N.F., Raynaud F.I., Rogers P., et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol Cancer Ther 2005, 4:1521-1532.
78. Zhang Y., Jiang Y., Geiser V., Zhou J., Jones C. Bovine herpesvirus 1 immediate-early protein (bICP0) interacts with the histone acetyltransferase p300, which stimulates productive infection and gC promoter activity. J Gen Virol 2006, 87:1843-1851.
79. Daujat S., Bauer U.M., Shah V., Turner B., Berger S., Kouzarides T. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol 2002, 12:2090-2097.
80. Wysocka J., Allis C.D., Coonrod S. Histone arginine methylation and its dynamic regulation. Front Biosci 2006, 11:344-355.
81. Ancelin K., Lange U.C., Hajkova P., Schneider R., Bannister A.J., Kouzarides T., et al. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 2006, 8:623-630.